|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: n/a.(b)(4).
|
|
On 24-oct-2024, the mentor failure analysis lab received the device for evaluation.On 28-oct-2024, mentor completed the investigation on the suspect medical device.Device evaluation summary: according to the information received, leakage of the saline solution was observed when attempting to implant the expander.The product was returned to mentor for evaluation.Mentor then conducted a visual inspection, leak testing, and microscopic examination of the returned device.Visual analysis of the returned sample determined that the tissue expander was painted blue.Additionally, the injection dome was received separately.Leak testing was performed, according to the mentor procedure, and two (2) tears (a & b) were found on the anterior view, measuring approximately 0.1 cm each.No other leak sites were found during the analysis.Microscopic examination was performed on the edges of the ruptures (a & b), and parallel striations were found in the whole area of both tears.Parallel striations are consistent with markings made by a sharp object perforating the tissue expander shell.Based on the information currently available, the microscopic examination of the returned product indicates that the expander could have been damaged during the implantation.The product insert data sheet cautions not to allow cautery devices or sharp instruments, such as scalpels, suture needles, hypodermic needles, hemostats, adson forceps, or scissors to contact the device during the implantation.As part of mentor¿s quality process, all devices are manufactured, inspected, and released to approved specifications.No corrective and preventive action (capa) is required now.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Manufacturer¿s reference number: (b)(4).
|